Blog Post

May 23, 2023

ReAlta CEO Attends BIO 2023 in Boston

ReAlta’s CEO Dr. Ulrich Thienel will be attending the BIO International Convention on Monday, June 5th through Thursday, June 8th in Boston.  Dr. Thienel will be meeting with investors and potential business partners to discuss the latest developments in our EPICC technology platform, including the upcoming Phase 2 clinical trial for our lead compound, RLS-0071, in hypoxic-ischemic encephalopathy (HIE).  Dr. Thienel will also share highlights from the presentation of exciting new data from the recently completed Phase 1b proof of mechanism study at this week’s American Thoracic Society 2023 annual meeting.


Oct 26, 2020

Facility Tours

Dr. Neel Krishna and Dr. Katherine LaVallee, DVM did an outstanding job leading tours of our lab and offices last...

Read More
Oct 21, 2020

New ReAlta Headquarters

We want to thank Rep. Elaine Luria and Norfolk Mayor Dr. Kenneth Alexander for helping us celebrate the official opening...

Read More
Apr 30, 2021

HIE Awareness Month

ReAlta Life Sciences is officially part of Team Hope! We are extending our gratitude to the Hope for HIE team...

Read More